{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:49:53Z","timestamp":1755794993845,"version":"3.44.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Controversy surrounds the indications for endoscopic treatment (ET) versus surgery in addressing gastrointestinal neuroendocrine neoplasms (GI-NENs). This paper aims to compare the long-term survival prognosis between ET and surgery for patients with GI-NENs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective analysis of GI-NEN patients diagnosed between 2000 and 2020 was conducted using the SEER database. Overall survival (OS) and cancer-specific survival (CSS) were estimated using the Kaplan-Meier method. Prognostic factors were assessed through univariate and multivariate Cox regression analyses. Propensity score matching (PSM) was employed to adjust for clinical variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study encompassed 12,016 patients with GI-NENs, with 3732 patients (31.1%) undergoing ET and 8284 patients (68.9%) opting for surgery. The rectum was the most frequent location for ET, while the small bowel was the predominant site for surgery. Both the ET and surgical groups exhibited similar overall survival risk and cancer-specific survival risk before and after matching. No significant differences in the 1-year, 3-year, 5-year, and 10-year OS and CSS rates were observed between the ET and surgery groups after PSM. Nevertheless, subgroup analysis revealed a significantly better CSS in the ET group than the surgery group, particularly in stage I and tumors sized &lt;10mm (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01). In the colon subgroup, the OS and CSS of the ET group were superior to those of the surgery group (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05).\u00a0<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Endoscopic treatment and surgery demonstrate comparable long-term survival prognoses for treating GI-NENs. ET emerges as a viable option for patients averse to surgical interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sle.0000000000001291","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T04:01:13Z","timestamp":1716264073000},"page":"366-375","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Endoscopic and Surgical Treatment of Gastrointestinal Neuroendocrine Neoplasms: A Population-based Comparative Study"],"prefix":"10.1097","volume":"34","author":[{"given":"Fuli","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8]]},"reference":[{"key":"R1-20250816","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.3390\/jcm12155138","article-title":"A comprehensive review on neuroendocrine neoplasms: Presentation, pathophysiology and management","volume":"12","author":"Sultana","year":"2023","journal-title":"J Clin Med"},{"key":"R2-20250816","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"R3-20250816","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.gtc.2022.06.002","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"51","author":"Fernandes","year":"2022","journal-title":"Gastroenterol Clin North Am"},{"key":"R4-20250816","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"R5-20250816","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ags3.12396","article-title":"Surgical treatment for gastrointestinal neuroendocrine tumors","volume":"4","author":"Eto","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"R6-20250816","doi-asserted-by":"crossref","first-page":"e13105","DOI":"10.1111\/jne.13105","article-title":"ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors","volume":"34","author":"Borbath","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"R7-20250816","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11864-022-00986-w","article-title":"State of the art in endoscopic therapy for the management of gastroenteropancreatic neuroendocrine tumors","volume":"23","author":"Papaefthymiou","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"R8-20250816","doi-asserted-by":"crossref","first-page":"e13306","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3","volume":"35","author":"Panzuto","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"R9-20250816","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/endrev\/bnad006","article-title":"Advances in the treatment of gastroenteropancreatic neuroendocrine carcinomas: Are we moving forward?","volume":"44","author":"Garcia-Carbonero","year":"2023","journal-title":"Endocr Rev"},{"key":"R10-20250816","doi-asserted-by":"crossref","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Shah","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"R11-20250816","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/a-1751-5742","article-title":"Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"54","author":"Deprez","year":"2022","journal-title":"Endoscopy"},{"key":"R12-20250816","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s11605-023-05800-y","article-title":"Surgical and endoscopic resection of duodenal neuroendocrine tumors have similar disease-specific survival outcome","volume":"27","author":"Mirzaie","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"R13-20250816","doi-asserted-by":"crossref","first-page":"15339","DOI":"10.1038\/s41598-022-19725-0","article-title":"Survival comparison between endoscopic and surgical resection for non-ampullary duodenal neuroendocrine tumor (1-2 cm)","volume":"12","author":"Xie","year":"2022","journal-title":"Sci Rep"},{"key":"R14-20250816","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/JS9.0000000000000336","article-title":"The impact of surgery and survival prediction in patients with gastroenteropancreatic neuroendocrine tumors: A population-based cohort study","volume":"109","author":"Wu","year":"2023","journal-title":"Int J Surg"},{"key":"R15-20250816","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/annonc\/mdv505","article-title":"Risk factors for neuroendocrine neoplasms: A systematic review and meta-analysis","volume":"27","author":"Leoncini","year":"2016","journal-title":"Ann Oncol"},{"key":"R16-20250816","doi-asserted-by":"crossref","first-page":"e13309","DOI":"10.1111\/jne.13309","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours","volume":"35","author":"Rinke","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"R17-20250816","doi-asserted-by":"crossref","first-page":"e13249","DOI":"10.1111\/jne.13249","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma","volume":"35","author":"Sorbye","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"R18-20250816","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/cncr.20939","article-title":"Early-stage carcinoids of the gastrointestinal tract: An analysis of 1914 reported cases","volume":"103","author":"Soga","year":"2005","journal-title":"Cancer"},{"key":"R19-20250816","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","article-title":"JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: Diagnosis, treatment, and follow-up: A synopsis","volume":"56","author":"Ito","year":"2021","journal-title":"J Gastroenterol"},{"key":"R20-20250816","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4240\/wjgs.v14.i4.276","article-title":"Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Stankiewicz","year":"2022","journal-title":"World J Gastrointest Surg"},{"key":"R21-20250816","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000443166","article-title":"ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms","volume":"103","author":"Ramage","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R22-20250816","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s00464-021-08535-6","article-title":"Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study","volume":"36","author":"Zhu","year":"2022","journal-title":"Surg Endosc"},{"key":"R23-20250816","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjsurg.2021.08.030","article-title":"Presentation and survival of gastro-entero-pancreatic neuroendocrine tumors in young adults versus older patients","volume":"223","author":"Nguyen","year":"2022","journal-title":"Am J Surg"},{"key":"R24-20250816","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cgh.2018.12.017","article-title":"Incidence trends of gastroenteropancreatic neuroendocrine tumors in the United. States.","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLE.0000000000001291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T20:05:43Z","timestamp":1755374743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLE.0000000000001291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/sle.0000000000001291","relation":{},"ISSN":["1534-4908"],"issn-type":[{"type":"electronic","value":"1534-4908"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"2023-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}